eltrombopag olamine

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

ELTROMBOPAG — HIKMA, approved 2026-04-08 (ANDA220033).

Most reported adverse events (US / FAERS)

18,409 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

platelet count decreased

3,969

death

3,315

drug ineffective

1,944

fatigue

1,108

Medicines containing this active substance

2 medicines

🇺🇸 Also approved in the US (FDA)

ELTROMBOPAG — HIKMA, approved 2026-04-08 (ANDA220033).

Most reported adverse events (US / FAERS)

18,409 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

platelet count decreased

3,969

death

3,315

drug ineffective

1,944

fatigue

1,108

platelet count increased

1,107

headache

968

off label use

890

nausea

809

diarrhoea

802

product use in unapproved indication

740

malaise

586

thrombocytopenia

582

pyrexia

548

asthenia

533

contusion

508